Abstract

Percutaneous Transvenous Mitral Commissurotomy (PTMC) is the first line treatment for rheumatic mitral stenosis (MS). We sought to evaluate (1) changes in 2-dimensional (2D) echocardiographic and strain values and (2) differences in these values for patients in atrial fibrillation (AF) and sinus rhythm (SR) pre, immediately and 6months post PTMC. Retrospective study of 136 patients who underwent PTMC between 2011 and 2021. We analyzed their 2D echocardiogram, Global Longitudinal Strain (GLS), Left Atrial Reservoir Strain (LAr-S) and Right Ventricle Free Wall Strain (RVFW-S) pre, immediately and 6months post PTMC. At 6months, mitral valve area increases from 0.94 ± 0.23cm2 to 1.50 ± 0.42cm2. Ejection fraction (EF) did not change post PTMC (pre; 55.56 ± 6.62%, immediate; 56.68 ± 7.83%, 6months; 56.28 ± 7.00%, p = 0.218). Even though EF is preserved, GLS is lower pre-procedure; -11.52 ± 3.74% with significant improvement at 6months; -15.16 ± 4.28% (p < 0.001). Tricuspid annular plane systolic excursion (TAPSE) improved at 6months from 1.95 ± 0.43 to 2.11 ± 0.49 (p = 0.004). RVFW-S increases at 6months from -17.37 ± 6.03% to -19.75 ± 7.19% (p = 0.011). LAr-S improved from 11.23 ± 6.83% pre PTMC to 16.80 ± 8.82% at 6months (p < 0.001) post PTMC. Pre-procedure patients with AF have lower strain values (More LV, RV and LA dysfunction) with statistically significant difference for LAr-S (p < 0.001), GLS (p < 0.001) and RVFW-S (p < 0.001) than patients in SR. Patients with severe rheumatic MS have subclinical left and right ventricle dysfunction despite preserved EF and relatively normal TAPSE with significant improvement seen at 6months post PTMC. AF patients have lower baseline strain values than SR patients.

Highlights

  • Percutaneous Transvenous Mitral Commissurotomy (PTMC) is an established treatment for severe rheumatic mitral stenosis (MS) since its first publication in 1984 [1]

  • At 6 months, mitral valve area increases from 0.94 ± 0.23cm2 to 1.50 ± 0.42cm2

  • Right Ventricle Free Wall Strain (RVFW-S) increases at 6 months from -17.37 ± 6.03% to -19.75 ± 7.19% (p

Read more

Summary

Introduction

Percutaneous Transvenous Mitral Commissurotomy (PTMC) is an established treatment for severe rheumatic mitral stenosis (MS) since its first publication in 1984 [1]. LV and RV dysfunction, there are prior studies showing reduction in Global Longitudinal Strain (GLS) and Right Ventricle Free Wall Strain (RVFW-S), but the study population is small, and these studies only analyzed pre and immediate post PTMC values [7,8,9,10,11,12,13,14]. To our knowledge, this is the first study that tracks all aspects of strain (GLS, RVFW-S and LAr-S) pre, immediately and 6 months post procedure. Atrial fibrillation (AF) commonly coexists with MS and there is no study far looking at baseline strain values and response to PTMC in this group of patients compared to those in sinus rhythm (SR) [15,16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call